S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
$0.01
$0.00
$3.46
$16K-2.3951,674 shsN/A
Histogenics Corp stock logo
HSGX
Histogenics
$1.32
-8.3%
$1.33
$0.08
$1.43
$124.87M3.19.06 million shs8.03 million shs
Ocugen, Inc. stock logo
OCGN
Ocugen
$1.32
-8.3%
$1.20
$0.35
$2.11
$338.58M3.518.15 million shs8.03 million shs
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
$1.15
-11.4%
$2.66
$1.15
$7.12
$4.67M1.2824,016 shs67,066 shs
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
$0.94
$0.56
$1.30
$63.04M2.3541,468 shs303,600 shs
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
0.00%0.00%0.00%0.00%+7,197.56%
Histogenics Corp stock logo
HSGX
Histogenics
-9.43%-20.00%+39.81%+176.92%+64.59%
Ocugen, Inc. stock logo
OCGN
Ocugen
-9.43%-20.00%+39.81%+178.75%+64.59%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
0.00%-19.65%-48.52%-48.90%-75.79%
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
0.00%0.00%0.00%+11.71%+56.71%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
N/AN/AN/AN/AN/AN/AN/AN/A
Histogenics Corp stock logo
HSGX
Histogenics
N/AN/AN/AN/AN/AN/AN/AN/A
Ocugen, Inc. stock logo
OCGN
Ocugen
0.8699 of 5 stars
3.51.00.00.02.90.00.0
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/AN/AN/AN/AN/AN/AN/AN/A
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
0.6184 of 5 stars
3.50.00.00.00.00.00.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
N/AN/AN/AN/A
Histogenics Corp stock logo
HSGX
Histogenics
N/AN/AN/AN/A
Ocugen, Inc. stock logo
OCGN
Ocugen
3.00
Buy$4.33228.28% Upside
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/AN/AN/AN/A
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
3.00
Buy$3.00∞ Upside

Current Analyst Ratings

Latest HSGX, OCGN, AHPI, POAI, and RWLK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/3/2024
Ocugen, Inc. stock logo
OCGN
Ocugen
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$7.00
2/22/2024
Ocugen, Inc. stock logo
OCGN
Ocugen
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$7.00
1/24/2024
Ocugen, Inc. stock logo
OCGN
Ocugen
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$5.00 ➝ $7.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
$27.05M0.00N/AN/A$1.30 per share0.00
Histogenics Corp stock logo
HSGX
Histogenics
N/AN/AN/AN/A($0.01) per shareN/A
Ocugen, Inc. stock logo
OCGN
Ocugen
$6.04M56.06N/AN/A$0.38 per share3.47
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
$1.78M2.62N/AN/A$2.04 per share0.56
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
$5.51M0.00N/AN/A$1.10 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
-$5.36M-$1.34N/AN/AN/AN/AN/AN/AN/A
Histogenics Corp stock logo
HSGX
Histogenics
-$8.64M-$0.79N/AN/AN/A-34.96%18.40%N/A
Ocugen, Inc. stock logo
OCGN
Ocugen
-$81.35M-$0.27N/AN/AN/AN/A-104.70%-81.96%5/3/2024 (Estimated)
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
-$13.98M-$3.47N/AN/A-785.62%-104.21%-70.49%5/20/2024 (Estimated)
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
-$19.57M-$0.37N/AN/AN/A-238.35%-29.00%-25.27%N/A

Latest HSGX, OCGN, AHPI, POAI, and RWLK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/28/2024Q4 2023
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/A-$0.85-$0.85-$0.85N/A$0.34 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
N/AN/AN/AN/AN/A
Histogenics Corp stock logo
HSGX
Histogenics
N/AN/AN/AN/AN/A
Ocugen, Inc. stock logo
OCGN
Ocugen
N/AN/AN/AN/AN/A
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/AN/AN/AN/AN/A
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
N/AN/AN/A
Histogenics Corp stock logo
HSGX
Histogenics
N/A
4.05
4.05
Ocugen, Inc. stock logo
OCGN
Ocugen
0.03
5.08
5.08
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/A
2.55
2.43
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
N/A
3.47
2.99

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
4.15%
Histogenics Corp stock logo
HSGX
Histogenics
40.35%
Ocugen, Inc. stock logo
OCGN
Ocugen
10.27%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
9.04%
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
3.58%

Insider Ownership

CompanyInsider Ownership
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
5.10%
Histogenics Corp stock logo
HSGX
Histogenics
19.70%
Ocugen, Inc. stock logo
OCGN
Ocugen
3.48%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
3.44%
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
2.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
1894.01 million3.81 millionNot Optionable
Histogenics Corp stock logo
HSGX
Histogenics
4994.60 millionN/ANot Optionable
Ocugen, Inc. stock logo
OCGN
Ocugen
84256.50 million247.58 millionOptionable
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
314.06 million3.92 millionNot Optionable
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
5660.03 million58.76 millionOptionable

HSGX, OCGN, AHPI, POAI, and RWLK Headlines

SourceHeadline
ReWalk Robotics Ltd. (LFWD)ReWalk Robotics Ltd. (LFWD)
finance.yahoo.com - April 18 at 7:42 AM
VA STAND Act introduced in the United States SenateVA STAND Act introduced in the United States Senate
globenewswire.com - March 22 at 8:30 AM
4 Must-Buy Efficient Stocks to Increase Your Portfolio Returns4 Must-Buy Efficient Stocks to Increase Your Portfolio Returns
zacks.com - March 19 at 8:36 AM
COMP.4500 Mobile Robotics (Formerly 91.450)COMP.4500 Mobile Robotics (Formerly 91.450)
uml.edu - March 18 at 4:46 AM
Lifeward Announces Reverse Share SplitLifeward Announces Reverse Share Split
globenewswire.com - March 13 at 11:45 AM
ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke TherapyReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy
globenewswire.com - March 8 at 8:30 AM
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be consideredLifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered
globenewswire.com - March 1 at 8:45 AM
ReWalk Robotics (LFWD) Reports Q4 Loss, Misses Revenue EstimatesReWalk Robotics (LFWD) Reports Q4 Loss, Misses Revenue Estimates
zacks.com - February 27 at 10:16 AM
Lifeward Reports Fourth Quarter and Full Year 2023 Financial ResultsLifeward Reports Fourth Quarter and Full Year 2023 Financial Results
globenewswire.com - February 27 at 8:00 AM
Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024
globenewswire.com - February 20 at 8:30 AM
Rewalk Robotics Ltd (LFWD)Rewalk Robotics Ltd (LFWD)
uk.investing.com - February 15 at 7:55 AM
Rewalk Robotics Ltd (RWLK)Rewalk Robotics Ltd (RWLK)
uk.investing.com - February 15 at 7:55 AM
ReWalk Robotics Ltd.ReWalk Robotics Ltd.
cnn.com - February 13 at 9:22 AM
7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market
finance.yahoo.com - February 6 at 5:23 PM
ReWalk Robotics looks to the future following Lifeward rebrandReWalk Robotics looks to the future following Lifeward rebrand
massdevice.com - February 5 at 10:12 AM
ReWalk Robotics Ltd. (DBA Lifeward): ReWalk Robotics Transforms Company Identity, Rebrands as LifewardReWalk Robotics Ltd. (DBA Lifeward): ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward
finanznachrichten.de - January 31 at 10:29 PM
Rewalk Robotics Rebrands as Lifeward, Announces New TickerRewalk Robotics Rebrands as Lifeward, Announces New Ticker
msn.com - January 31 at 5:29 PM
Following acquisition, ReWalk rebrands to new name to reflect broader offeringsFollowing acquisition, ReWalk rebrands to new name to reflect broader offerings
wbjournal.com - January 29 at 1:02 PM
ReWalk Robotics (NASDAQ:RWLK investor five-year losses grow to 82% as the stock sheds US$10m this past weekReWalk Robotics (NASDAQ:RWLK investor five-year losses grow to 82% as the stock sheds US$10m this past week
finance.yahoo.com - January 15 at 10:12 AM
ReWalk Robotics Expands Direct Sales Coverage to CanadaReWalk Robotics Expands Direct Sales Coverage to Canada
finance.yahoo.com - January 12 at 1:43 PM
ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17
finance.yahoo.com - January 11 at 8:35 PM
ReWalk Robotics Ltd.: First ReWalk Personal Exoskeleton Claim Paid by MedicareReWalk Robotics Ltd.: First ReWalk Personal Exoskeleton Claim Paid by Medicare
finanznachrichten.de - January 5 at 4:14 PM
First ReWalk Personal Exoskeleton Claim Paid by MedicareFirst ReWalk Personal Exoskeleton Claim Paid by Medicare
finance.yahoo.com - January 5 at 9:07 AM
ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational PrioritiesReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities
finance.yahoo.com - January 4 at 9:23 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Allied Healthcare Products logo

Allied Healthcare Products

NASDAQ:AHPI
Allied Healthcare Products, Inc. engages in manufacturing respiratory products used in the health care industry in hospitals and alternate site settings, including sub-acute care facilities, home health care and emergency medical care. Its product line includes respiratory care products, medical gas equipment, and emergency medical products. The company was founded in 1979 and is headquartered in St. Louis, MO.
Histogenics logo

Histogenics

NASDAQ:HSGX
Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.
Ocugen logo

Ocugen

NASDAQ:OCGN
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410 and OCU410ST for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. It has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Predictive Oncology logo

Predictive Oncology

NASDAQ:POAI
Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.
ReWalk Robotics logo

ReWalk Robotics

NASDAQ:RWLK
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.